Bmc Oaspa Webinar

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

0 comments

Post a comment

    Post a comment
    Embed Video
    Edit your comment Cancel

    Favorites, Groups & Events

    Bmc Oaspa Webinar - Presentation Transcript

    1. BioMed Central and OA Publishing Matthew Cockerill Managing Director, BioMed Central OASPA Webinar, 20th October 2009
    2. About BioMed Central  Largest publisher of peer-reviewed OA journals  Launched first open access journal in 2000  Now publishes 202 OA titles  >60,000 peer-reviewed OA articles published  All research articles published under Creative Commons license  Costs covered by 'article processing charge' (APC)  Part of Springer Science+Business Media since October 2008
    3. BioMed Central revenue streams  Publication fees – From authors – From meeting organizers – From sponsoring institutions/organizations  Subscription content (e.g. reviews)  Services (e.g. Open Repository)  Advertising / sponsorship
    4. BioMed Central revenue streams  Publication fees – From authors – From meeting organizers – From sponsoring institutions/organizations  Subscription content (e.g. reviews)  Services (e.g. Open Repository)  Advertising / sponsorship
    5. BioMed Central membership  Prepay membership – Institution pays APCs centrally at a discounted rate – Authors do not have to pay  Supporter membership – Institutions pay a flat fee – Authors pay a discounted Article Processing Charge
    6. How do publication fees get paid? (last 12 months) Prepay membership 18% Individual payment (Standard) Individual 54% payment (Supporter member) 16% Promotional waivers 7% Low income country waivers Discretionary 2% waivers 3%
    7. Rejection rates and the open access model  High prestige journals often have a high rejection rate  Lots of submissions, few publications  How to make economically viable under Open Access? – Higher APC? – Submission fee? – Cascade model?
    8. Journal peer review cascade High rejection rate Moderate rejection rate Low rejection rate
    9. Advantages of peer review cascade  Avoids delays for authors  Avoids saddling academics with repeated peer review of less interesting papers  Separates question of soundness of research from level of interest – Soundness determines whether to publish – Interest determines where to publish
    10. Is OA publishing still growing?
    11. 1000 2000 3000 4000 5000 6000 7000 8000 0 apr.00 okt.00 apr.01 okt.01 apr.02 okt.02 apr.03 okt.03 apr.04 okt.04 apr.05 okt.05 apr.06 okt.06 submissions apr.07 okt.07 apr.08 okt.08 apr.09 Growth in quarterly manuscipt
    12. Growth rate is increasing 20000 50% 41% 40% 15000 30% Submissions 28% 10000 (Jan-Aug) 19% 20% 18% %ge growth on 5000 previous year 10% 0 0% 2006 2007 2008 2009
    13. What factors are helping BioMed Central to grow?
    14. Google pagerank Similarly: Cell Biology Molecular Biology Systems Biology Bioinformatics Developmental Biology All on first page of Google results
    15. BioMed Central journals with official Thomson Reuters/ISI impact factors No. of journals with Impact Factor 70 60 50 40 30 20 10 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
    16. Journal transfers
    17. Established titles are moving to OA with BioMed Central
    18. Increasing visibility and increasing impact for a society journal Acta Veterinaria Scandinavica Moved to 1 BioMed Central and became 0.899 Open Access Impact Factor 0.8 0.717 0.6 0.408 0.375 0.4 0.318 0.2 0 2004 2005 2006 2007 2008
    19. Helping authors to comply with institutional Open Access policies
    20. Manual deposit to IR 1 Publisher Manuscript 2 Institutional Repository Author (DSpace/Eprints etc.) final version
    21. Automated deposit to IR via SWORD SWORD Export Manuscript Published articles from SWORD institution’s Import authors Institutional Repository Published (DSpace/Eprints etc.) article

    custom

    70 views, 0 favs, 1 embeds more stats

    Presentation by panelist Matthew Cockerill, BioMed more

    More info about this document

    © All Rights Reserved

    Go to text version

    • Total Views 70
      • 50 on SlideShare
      • 20 from embeds
    • Comments 0
    • Favorites 0
    • Downloads 0
    Most viewed embeds
    • 20 views on http://www.oaspa.org

    more

    All embeds
    • 20 views on http://www.oaspa.org

    less

    Flagged as inappropriate Flag as inappropriate
    Flag as inappropriate

    Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

    Cancel
    File a copyright complaint
    Having problems? Go to our helpdesk?

    Categories